Immunogenicity and its impact on benefit/risk considerations in the authorisation of biopharmaceuticals. [electronic resource]
Producer: 20110125Description: 287-92 p. digitalISSN:- 2212-3911
No physical items for this record
Publication Type: Guideline; Journal Article
There are no comments on this title.
Log in to your account to post a comment.